GIA
CL icon

Gladstone Institutional Advisory’s Colgate-Palmolive CL Stock Holding History

Gladstone Institutional Advisory’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$604K Buy
6,588
+727
+12% +$63.6K 0.02% 534
2026
Q1 		$500K Sell
5,861
-100
-2% -$8.91K 0.02% 537
2025
Q4 		$471K Sell
5,961
-841
-12% -$65.9K 0.02% 509
2025
Q3 		$544K Sell
6,802
-37
-0.5% -$3.16K 0.02% 496
2025
Q2 		$622K Buy
6,839
+115
+2% +$10.5K 0.03% 442
2025
Q1 		$630K Sell
6,724
-11
-0.2% -$985 0.03% 416
2024
Q4 		$612K Sell
6,735
-23
-0.3% -$2.19K 0.03% 419
2024
Q3 		$702K Buy
6,758
+631
+10% +$64.3K 0.03% 373
2024
Q2 		$595K Sell
6,127
-53
-0.9% -$4.89K 0.03% 386
2024
Q1 		$557K Sell
6,180
-1,506
-20% -$128K 0.03% 388
2023
Q4 		$613K Buy
7,686
+2,028
+36% +$152K 0.03% 375
2023
Q3 		$402K Sell
5,658
-533
-9% -$39.9K 0.03% 429
2023
Q2 		$477K Sell
6,191
-138
-2% -$10.7K 0.03% 403
2023
Q1 		$476K Buy
6,329
+133
+2% +$9.89K 0.03% 417
2022
Q4 		$488K Buy
6,196
+158
+3% +$11.8K 0.03% 400
2022
Q3 		$424K Sell
6,038
-440
-7% -$34.5K 0.03% 428
2022
Q2 		$519K Sell
6,478
-855
-12% -$66.9K 0.04% 404
2022
Q1 		$556K Buy
7,333
+59
+0.8% +$4.67K 0.04% 408
2021
Q4 		$621K Buy
7,274
+98
+1% +$7.65K 0.05% 337
2021
Q3 		$542K Buy
7,176
+3,210
+81% +$255K 0.05% 306
2021
Q2 		$323K Buy
3,966
+377
+11% +$30.8K 0.04% 381
2021
Q1 		$283K Buy
3,589
+796
+28% +$62.4K 0.04% 329
2020
Q4 		$239K Sell
2,793
-73
-3% -$6.04K 0.05% 269
2020
Q3 		$221K Buy
+2,866
New +$219K 0.05% 241
2020
Q2 		– Sell
-3,699
Closed -$246K – 253
2020
Q1 		$246K Buy
3,699
+56
+2% +$3.95K 0.06% 216
2019
Q4 		$251K Sell
3,643
-367
-9% -$25K 0.06% 223
2019
Q3 		$295K Buy
4,010
+463
+13% +$33.6K 0.08% 207
2019
Q2 		$254K Buy
+3,547
New +$252K 0.08% 219

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Gladstone Institutional Advisory's CL Position: Q2 2026 in Review

Gladstone Institutional Advisory increased its Colgate-Palmolive (CL) stake by 12% in Q2 2026, buying an estimated $63.6K and bringing the position to 6,588 shares worth $604K. The position accounts for 0.02% of the portfolio, ranked #534.

Gladstone Institutional Advisory first reported a position in CL in Q2 2019 and has held it in 28 quarters since. The position peaked at $702K in Q3 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Gladstone Institutional Advisory held 6,588 shares of Colgate-Palmolive worth $604K as of Q2 2026.
  • Gladstone Institutional Advisory bought 727 Colgate-Palmolive shares in Q2 2026, an estimated $63.6K.
  • Colgate-Palmolive made up 0.02% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #534 holding.
  • Gladstone Institutional Advisory first reported a position in Colgate-Palmolive in Q2 2019 and has held it in 28 quarters since.
  • Gladstone Institutional Advisory's Colgate-Palmolive position peaked at $702K in Q3 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.